The hallmark of
cancer care is often the availability of clinical
trials. Our clinical research coordinator can tell you what trials
are available and how to access them. She can also answer questions
about cancer research and the importance of considering a clinical
trial as part of your decision tree.
Lee Cancer Care is participating in the
following National Cancer Institute (NCI) cooperative groups:
- ECOG (Eastern Cooperative Oncology Group)
- GOG (Gynecology Oncology Group)
This means that the newest treatment protocols and the latest cancer
fighting drugs are available. Lee Cancer Care has access to
leading-edge protocols with hopes of finding greater success in the
treatment of all cancer patients.
We currently
have available clinical trials for Breast Cancer, Ovarian or Primary
Peritoneal, Endometrial (Uterine), Cervical, Vulva, Leukemia and
Melanoma. Please contact the Clinical Research Coordinator to learn
more about eligibility for these clinical trials at 877-680-0008.
Clinical Trials are
studies that are conducted with human subjects that consist of giving
specific drugs in an orderly, carefully planned way. The purpose of
clinical trials is to evaluate the effectiveness and safety of a
particular intervention or drug regimen in preventing, treating or
eliminating a disease. Clinical trials can also evaluate whether a
particular regimen improves upon the current treatment, which is often
referred to as the standard of care. The Food and Drug Administration
(FDA) and the institutional IRB (Institutional Review Board) approve
all clinical trials. Clinical Trials go through a standard process or
phase and each phase has specific goals. The Phases of a Clinical
Trial are identified as: Phase I, Phase II, Phase III or Phase IV. |
